Cardiology
Pathophysiology and preventive strategies of anthracycline-induced cardiotoxicity
Woo-Baek Chung, Ho-Joong Youn
Korean J Intern Med. 2016;31(4):625-633. Published online July 1, 2016
Cardiotoxicity is a well-known complication following treatment with anthracyclines. However, they are still widely used in chemotherapy for breast cancer, lymphoma, leukemia, and sarcoma, among others. Patient clinical characteristics, such as age, sex, comorbidities, anthracycline dose and infusio..
|